Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-02-11T10:20:06.208Z Has data issue: false hasContentIssue false

DOES CLINICAL TRIAL SUBJECT SELECTION RESTRICT THE ABILITY TO GENERALIZE USE AND COST OF HEALTH SERVICES TO “REAL LIFE” SUBJECTS?

Published online by Cambridge University Press:  22 January 2003

Wendy A. Kennedy
Affiliation:
University of Montreal
Claudine Laurier
Affiliation:
University of Montreal
Jean-Luc Malo
Affiliation:
Hôpital du Sacré Coeur de Montréal
Heberto Ghezzo
Affiliation:
Meakins Christie Laboratories
Jocelyne L'archevêque
Affiliation:
Hôpital du Sacré Coeur de Montréal
André-Pierre Contandriopoulos
Affiliation:
University of Montreal
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Objectives: To explore one aspect of the external validity of the randomized controlled trial (RCT), specifically how being selected for inclusion in a trial and having participated has influenced the use and cost of asthma-related health services.

Methods: Services used by asthmatic users of inhaled corticosteroids (iCSTs) having previously participated in an RCT (TS, n = 46) were compared with individuals who had never participated (NS, n = 51).

Results: TS were more likely to use higher (≥400 μg) daily doses of iCSTs than NS (OR, 3.3; 95% CI, 1.1–8.3) but less likely to visit emergency departments (OR, 0.3; 95% CI, 0.1–0.7). Total asthma-related costs did not differ significantly.

Conclusions: Subject differences may impede generalizing from RCTs to real life.

Type
GENERAL ESSAYS
Copyright
© 2003 Cambridge University Press